2 completed, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow BI 1291583: new trials by email Literature Review of BI 1291583 trials Research Report on BI 1291583
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) BI 1291583, Placebo to BI 1291583 - Cystic Fibrosis, Bronchiectasis | Phase 2 | Completed | Boehringer Ingelheim | 22 | 2024-04-05 | 2026-06-23 |
| Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine BI 1291583, Placebo matching BI 1291583 - Bronchiectasis | Phase 2 | Active not recruiting | Boehringer Ingelheim | 268 | 2023-09-08 | 2026-10-14 |
| A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis BI 1291583, Placebo - Bronchiectasis | Phase 2 | Completed | Boehringer Ingelheim | 322 | 2022-04-28 | 2026-07-28 |
Bronchiectasis (3) · Cystic Fibrosis (1)
Belgium (3) · France (3) · Germany (3) · Italy (3) · Netherlands (3) · Spain (3) · United States (3) · Australia (2) · Bulgaria (2) · Canada (2) · Czechia (2) · Denmark (2) · Hungary (2) · Israel (2) · Japan (2)
2023 (1)